The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with ...

Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, ...

Intravenous thrombolysis remains a standard treatment for acute ischemic stroke within 4.5 hours after onset. Vascular reocclusion may occur after intravenous thrombolysis and may be preventable ...

When Microsoft AI announced one of its systems solved complex medical cases more accurately and cost-effectively than expert ...

Despite the strong performance of Microsoft’s medical AI MAI-DxO in testing, which included models from OpenAI, Google, ...

Forensic pathologists play a unique role in monitoring and responding to public health threats and advancing our ...

Microsoft’s MAI-DxO hits 85.5% diagnostic accuracy and cuts costs by 20%, outperforming human doctors and top AI models in ...

Once-weekly cagrilintide–semaglutide combination therapy produced unprecedented weight reductions in adults with overweight or obesity, with 60% achieving ≥20% loss and strong cardiometabolic benefits ...

Microsoft has introduced the MAI Diagnostic Orchestrator, an advanced AI system that diagnoses complex medical conditions ...

Learn how to cite references in a grant proposal using different citation styles and avoid common citation errors. Citing references is essential for your credibility, relevance, and originality.

Non-Matching Reference-based Speech Quality Assessment models typically require numerous references during inference to ensure stable and accurate predictions. However, this dependency introduces ...

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of ...